Also available in Persian — نسخه فارسی EN فا
❓ Unknown

David Lynch has been diagnosed with chronic lung disease

Jan 24, 2026 January 24, 2026 2 min read 📰 Radio Farda
📋 Key Takeaway

David Lynch has been diagnosed with emphysema, a chronic lung disease caused by years of smoking. Despite this, he remains optimistic and plans to continue working remotely. This diagnosis highlights the health risks associated with smoking and the impact of chronic diseases.

🔍 Quick Context Guide
💡 Bottom Line: David Lynch's emphysema diagnosis underscores the long-term health consequences of smoking while he remains committed to his work.

👥 Key Players

David Lynch MENTIONED
American film director
"Lynch is a highly influential figure in cinema, known for his unique storytelling and contributions to the film industry."

📰 What Happened

David Lynch has announced his diagnosis of emphysema, a chronic lung disease caused by years of smoking. Despite this setback, he remains optimistic about continuing his work remotely.

  • Lynch has quit smoking two years ago.
  • Emphysema is predicted to become the third leading cause of death worldwide by 2030.

💡 Why It Matters

🇮🇷 For Iran: The health implications of smoking and chronic diseases can resonate with Iranian audiences, where smoking rates are also a public health concern.
🌍 Regional: The announcement may raise awareness about health issues in the region, particularly among artists and public figures.
🌐 International: Lynch's situation highlights the broader health risks associated with smoking, prompting discussions on public health policies.

📚 Background

Emphysema is a serious lung condition that affects breathing and is often linked to smoking. Lynch's career has been marked by innovative storytelling in film and television.

Chronic obstructive pulmonary disease (COPD) Public health and smoking cessation
📡 Source: NEUTRAL
📊 Confidence: 70%
The information is based on Lynch's own statements and widely reported health facts, making it a reliable account of his situation.

David Lynch, the prominent American director, announced that he has been diagnosed with a chronic lung disease. In an interview with the British magazine 'Sight and Sound', Mr. Lynch stated that doctors have informed him that his lungs are affected by emphysema, which is a type of chronic obstructive pulmonary disease. This condition has occurred due to 'years of smoking' and has damaged the air sacs in his lungs. These damages lead to respiratory problems, including shortness of breath, chronic cough, and frequent chest infections. The 78-year-old director added that despite this diagnosis, he is still in 'great shape' and declared that he 'will never retire'. Lynch also mentioned that this illness has limited his mobility and that he will now only be able to direct films remotely. In a message recently posted on the social media platform X, Mr. Lynch wrote that this illness is 'the price I have to pay for years of smoking'. He also announced that he quit smoking two years ago. Lynch further stated that despite his illness, he is 'full of joy' and thanked his fans for their concerns. David Lynch has directed ten feature films and has been nominated for an Oscar for four films, including 'Mulholland Drive' and 'Blue Velvet'. In a 2003 poll of film critics worldwide conducted by The Guardian, he was voted 'the greatest living filmmaker in the world'. David Lynch is also famous for creating the groundbreaking series 'Twin Peaks'. The third season of this series, which aired in 2017, is his latest project. The emphysema that has confined this American director is primarily caused by smoking, air pollution, and exposure to dust and industrial chemicals. The World Health Organization has predicted that emphysema will become the third leading cause of death worldwide by 2030.

🌐

Translated from the original and edited for English readers. View original source →

Translation confidence: 85%

📰 Related Coverage

⚖️ Independent Platform — Artesh.com is not affiliated with any government, military, or political organization. Editorial Policy →